Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posiphen in Early Alzheimer's and Parkinson's Disease
NCT04524351Phase 2Completed
- Sponsor
- Annovis Bio, Inc.
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buntanetap in Alzheimer's disease (AD), Parkinson's disease (PD), sponsored by Annovis Bio, Inc.. Started Aug 2020; status: completed.
02
Drugs
buntanetap
03
Conditions
Alzheimer's disease (AD)Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04524351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04524351.